Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$85.9M | 6.2 | 71.2% | (2,855.4%) | (2,816.0%) | (2,597.6%) | (2,084.0%) | 80.2% | |
$402.0B | 8.3 | 84.7% | 44.3% | 51.2% | 34.8% | 24.1% | 69.4% | |
$125.5B | 6.8 | 86.1% | (2.2%) | 4.4% | (4.9%) | (7.2%) | 147.6% | |
$74.0B | 8.1 | 86.7% | 28.3% | 33.1% | 31.1% | 25.3% | 81.5% | |
$38.1B | 5.9 | 86.8% | (17.1%) | (2.1%) | (4.5%) | (9.4%) | 103.2% | |
$31.3B | 5.3 | 85.6% | (7.9%) | (8.6%) | (12.4%) | (1.9%) | 15.3% | |
$27.1B | 6.7 | 84.3% | (30.8%) | (12.2%) | (15.4%) | 32.4% | (312.1%) | |
$14.8B | 7.0 | 92.3% | 1.5% | 6.2% | 0.8% | 5.5% | 721.1% | |
$14.6B | 5.7 | N/A | N/A | N/A | N/A | N/A | 64.2% | |
$14.0B | 9.1 | 89.2% | 47.9% | 55.9% | 41.5% | 37.6% | 90.4% | |
$1,846.9M | 5.8 | 83.1% | (26.3%) | (22.0%) | (25.9%) | (30.4%) | 117.3% |
The Cabaletta Bio, Inc. (CABA) gross profit margin is 71.2%, compared to the industry median of 65.7% and the 5-year historical average of 56.8%.
The Cabaletta Bio, Inc. (CABA) operating income margin is (2,597.6%), compared to the industry median of (855.0%)) and the 5-year historical average of (2,111.5%).
The Cabaletta Bio, Inc. (CABA) Free Cash Flow margin is (2,084.0%), compared to the industry median of (726.1%) and the 5-year historical average of (1,742.6%).
The Cabaletta Bio, Inc. (CABA) earnings quality is 80.2%, compared to the industry median of 83.4% and the 5-year historical average of 85.5%.